BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3306936)

  • 21. Cell differentiation and iodine-131 uptake in poorly differentiated thyroid tumour in response to nevirapine.
    Landriscina M; Modoni S; Fabiano A; Fersini A; Barone C; Ambrosi A; Cignarelli M
    Lancet Oncol; 2006 Oct; 7(10):877-9. PubMed ID: 17012051
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma.
    Pelizzo MR; Merante Boschin I; Toniato A; Pagetta C; Casal Ide E; Mian C; Rubello D
    Minerva Endocrinol; 2008 Dec; 33(4):359-79. PubMed ID: 18923371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Papillary thyroid cancer in Saudi Arabia. Clinical, pathologic, and management characteristics.
    al-Nuaim AR; Ahmed M; Bakheet S; Abdul Kareem AM; Ingmenson S; al-Ahmari S; al-Saihati B; Ali MA; Akthar M
    Clin Nucl Med; 1996 Apr; 21(4):307-11. PubMed ID: 8925614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occult parathyroid carcinoma in a patient with papillary thyroid carcinoma and Hashimoto's thyroiditis.
    Savli H; Sevinc A; Sari R; Ozen S; Buyukberber S; Ertas E
    J Endocrinol Invest; 2001 Jan; 24(1):42-4. PubMed ID: 11227731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of locally aggressive well-differentiated thyroid cancer.
    Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ
    Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytologic changes mimicking papillary carcinoma of the thyroid after 131I treatment.
    Saqi A; Hoda RS; Kuhel WI; Vazquez M; Hoda SA
    Acta Cytol; 1999; 43(5):971-2. PubMed ID: 10518149
    [No Abstract]   [Full Text] [Related]  

  • 28. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
    McHenry C; Jarosz H; Lawrence AM; Paloyan E
    Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid cancer presentation and treatment in the United States.
    Enewold L; Harlan LC; Stevens JL; Sharon E
    Ann Surg Oncol; 2015; 22(6):1789-97. PubMed ID: 25361888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follow-up of thyroid cancer patients with favorable prognostic indicators.
    Leboulleux S; Baudin E; Schlumberger M
    Ann Endocrinol (Paris); 2003 Feb; 64(1):64-7. PubMed ID: 12707639
    [No Abstract]   [Full Text] [Related]  

  • 32. [Follow-up care for differentiated thyroid cancer].
    Hüfner M; Reiners C
    Dtsch Med Wochenschr; 1986 Nov; 111(45):1732-4. PubMed ID: 3536387
    [No Abstract]   [Full Text] [Related]  

  • 33. Current perspectives on papillary carcinoma of the thyroid gland.
    Chiu MK; Sherry RM; Wei JP
    J Med Assoc Ga; 1992 Aug; 81(8):442-4. PubMed ID: 1512532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Papillary thyroid cancer: a pediatric perspective.
    Flannery TK; Kirkland JL; Copeland KC; Bertuch AA; Karaviti LP; Brandt ML
    Pediatrics; 1996 Sep; 98(3 Pt 1):464-6. PubMed ID: 8784379
    [No Abstract]   [Full Text] [Related]  

  • 35. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
    Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S
    J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment and prognosis of tracheal invasion by papillary thyroid carcinoma].
    Xu XF; Wang X; Yin XM; Li ZT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Apr; 41(4):284-8. PubMed ID: 16848179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Differentiated thyroid carcinoma: survival and prognostic factors].
    Sastre Marcos J; Llamazares Iglesias O; Vicente Delgado A; Marco Martínez A; Cánovas Gaillemin B; Orradre Romero JL; Morlan López MÁ; López López J
    Endocrinol Nutr; 2011 Apr; 58(4):157-62. PubMed ID: 21419724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The characteristics of the clinical course and therapy of thyroid cancer in children].
    Rozdil'skiĭ SI; Afanas'eva NI; Nachinova NA; Tkachenko GI; Astap'eva ON; Vasil'ev LIa; Duma VA
    Ter Arkh; 1992; 64(10):55-8. PubMed ID: 1485257
    [No Abstract]   [Full Text] [Related]  

  • 40. Well differentiated thyroid cancer.
    Caron NR; Clark OH
    Scand J Surg; 2004; 93(4):261-71. PubMed ID: 15658666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.